Back to RXRX
STATE STREET CORP RXRX Position History
Recursion Pharmaceuticals, Inc.
Quarters held
12
Latest value
$127.4M
Q2 2026
Peak value
$127.4M
First seen
Q4 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2023 | $119.8M |
| Q1 2024 | $103.2M |
| Q2 2024 | $65.6M |
| Q3 2024 | $84.8M |
| Q4 2024 | $85M |
| Q1 2025 | $69.2M |
| Q2 2025 | $56.6M |
| Q3 2025 | $89.2M |
| Q4 2025 | $103.6M |
| Q1 2026 | $87.5M |
| Q2 2026 | $127.4M |
| Q2 2026 | $127.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $127.4M | 34.71M | — | — |
| Q2 2026 | $127.4M | 34.71M | — | — |
| Q1 2026 | $87.5M | 28.49M | — | — |
| Q4 2025 | $103.6M | 25.33M | — | — |
| Q3 2025 | $89.2M | 18.27M | — | — |
| Q2 2025 | $56.6M | 11.18M | — | — |
| Q1 2025 | $69.2M | 13.09M | — | — |
| Q4 2024 | $85M | 12.58M | — | — |
| Q3 2024 | $84.8M | 12.87M | — | — |
| Q2 2024 | $65.6M | 8.75M | — | — |
| Q1 2024 | $103.2M | 10.35M | — | — |
| Q4 2023 | $119.8M | 12.15M | — | — |